10/16/2012

FDA's Office of Prescription Drug Promotion told Roche Holding unit Genentech to change its ads for Tarceva, approved to treat pancreatic and nonsmall-cell lung cancers. Regulators said some images were misleading and overstated efficacy.

Related Summaries